http://orcid.org/0000-0003-1657-4044
References
- Suleymanlar G, Utas C, Arinsoy T, et al. A population-based survey of chronic renal disease in Turkey–the CREDIT study. Nephrol Dial Transplant. 2011;26:1862–1871.
- Kim WH, Park JY, Ok SH, et al. Association between the neutrophil/lymphocyte ratio and acute kidney injury after cardiovascular surgery: a retrospective observational study. Medicine (Baltimore). 2015;94:e1867.
- Neuen BL, Leather N, Greenwood AM, et al. Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Ren Fail. 2016;38:70–76.
- Luo Y, She DL, Xiong H, et al. Pretreatment neutrophil to lymphocyte ratio as a prognostic predictor of urologic tumors: a systematic review and meta-analysis. Medicine (Baltimore). 2015;94:e1670.
- Yin Y, Wang J, Wang X, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis. Clinics (Sao Paulo). 2015;70:524–530.
- Goh BK, Chok AY, Allen JC, Jr, et al. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Surgery. 2016;159:1146–1156.
- Liu X, Zhang Q, Wu H, et al. Blood neutrophil to lymphocyte ratio as a predictor of hypertension. Am J Hypertens. 2015;28:1339–1346.
- Wagdy S, Sobhy M, Loutfi M. Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events, new-onset atrial fibrillation, and no-reflow phenomenon in patients with ST elevation myocardial infarction. Clin Med Insights Cardiol. 2016;10:19–22.
- Suppan C, Bjelic-Radisic V, La Garde M, et al. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer. 2015;15:1027.
- Cai YJ. Role of neutrophil to lymphocyte ratio in the prognosis of male patients with hepatocellular carcinoma undergoing liver transplantation. Hepatol Res. 2016;46:1168.
- Huang J, Dahl DM, Dong L, et al. Preoperative neutrophil-to-lymphocyte ratio and neutrophilia are independent predictors of recurrence in patients with localized papillary renal cell carcinoma. Biomed Res Int. 2015;2015:891045.
- Halazun KJ, Marangoni G, Hakeem A, et al. Elevated preoperative recipient neutrophil-lymphocyte ratio is associated with delayed graft function following kidney transplantation. Transplant Proc. 2013;45:3254–3257.
- Okyay GU, Inal S, Onec K, et al. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35:29–36.
- Turkmen K, Guney I, Yerlikaya FH, et al. The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients. Ren Fail. 2012;34:155–159.
- Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911.
- Cankaya E, Bilen Y, Keles M, et al. Neutrophil-lymphocyte ratio is significantly decreased in preemptive renal transplant patients. Transplant Proc. 2015;47:1364–1368.
- Ahbap E, Sakaci T, Kara E, et al. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol. 2016;85:199–208.
- Turkmen K, Erdur FM, Ozcicek F, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17:391–396.
- Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–924.
- Thompson RH. Partial versus radical nephrectomy: the debate regarding renal function ends while the survival controversy continues. Eur Urol. 2014;65:378–379.
- Lai TC, Ma WK, Yiu MK. Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go. Hong Kong Med J. 2016;22:39–45.